Title page for 985302023


[Back to Results | New Search]

Student Number 985302023
Author Hsiang-yeh Wu(d~)
Author's Email Address No Public.
Statistics This thesis had been viewed 382 times. Download 146 times.
Department Executive Master of Computer Science and Information Engineering
Year 2010
Semester 2
Degree Ph.D.
Type of Document Doctoral Dissertation
Language English
Title The Risk Factors and Components Change in Metabolic Syndrome One Year Incidence and Recovery
Date of Defense 2011-07-27
Page Count 53
Keyword
  • Incednece
  • Metabolic syndrome
  • Recovery
  • Abstract In recent years, because of the diet culture and the lifestyle change, cardiacerebrovascular
    disease, hypertension, diabetes and other chronic diseases have
    replaced infectious diseases and slowly endanger people's health. In past years, we
    generally believed that blood pressure, blood lipids and blood glucose still in the
    normal range are healthy. However, in clinic, if many risk factors are closer to
    abnormal range, the chronic diseases will be occurred. Therefore, in the perspective of
    preventive medicine, we more care about the symptoms before disease - Metabolic
    Syndrome.
    Some metabolic syndrome (MetS) research focused on the association of the
    variation of components with the incidence of MetS, except the BMI and weight
    change, and few has been reported on recovery of MetS. In this study, we collected
    the community outreaching project data during 2003 to 2009 in Li-shin hospital.
    And we used the logistic regression to analyse the relationship of the risk factors and
    the change of components in one year recovery and incidence of MetS.
    Table of Content Kn............................................................................................................................... I
    ABSTRACT ................................................................................................................. II
    P............................................................................................................................. III
    TABLE OF CONTENTS .......................................................................................... IV
    LIST OF TABLE ....................................................................................................... VI
    LIST OF FIGTURE ................................................................................................. VII
    CHAPTER 1 INTRODUCTION ............................................................................. 1
    1.1 BACKGROUND ....................................................................................................... 1
    1.2MOTIVATION .......................................................................................................... 2
    1.3 GOAL ..................................................................................................................... 2
    CHAPTER 2 RELATED WORKS .......................................................................... 3
    2.1METABOLIC SYNDROME ........................................................................................ 3
    2.2 LOGISTIC REGRESSION .......................................................................................... 6
    CHAPTER 3 METHODS AND MATERIALS ...................................................... 7
    3.1 SYSTEM FLOW ....................................................................................................... 7
    3.2 STUDY POPULATION .............................................................................................. 8
    3.3ANTHROPOMETRIC MEASUREMENTS AND BLOOD PRESSURE MEASURES .............. 9
    3.4 BIOCHEMICAL PARAMETERS ................................................................................ 10
    3.5MAJOR LIFESTYLE VARIABLES ............................................................................ 10
    3.6 DEFINITIONS OF METABOLIC SYNDROME ............................................................ 10
    3.7 STATISTICAL ANALYSIS ........................................................................................ 11
    CHAPTER 4 RESULTS ......................................................................................... 14
    4.1 STATISTICAL RESULT AT BASELINE ...................................................................... 14
    4.2 ONE YEAR INCIDENCE AND RECOVERY ............................................................... 16
    4.3 UNIVARIATE AND MULTIVARIATE LOGISTIC REGRESSION ANALYSIS ................... 21
    4.3.1 Metabolic Abnormalities ............................................................................. 21
    4.3.2 Change of Risk Factors and Components ................................................... 24
    V
    4.3.3 Medication Use ............................................................................................ 30
    CHAPTER 5 DISCUSSION .................................................................................. 34
    CHAPTER 6 CONCLUSION AND FUTURE WORKS ..................................... 38
    REFERENCES ........................................................................................................... 39
    Reference 1. Reaven, G.M., Role of insulin resistance in human disease (syndrome X): an
    expanded definition. Annu Rev Med, 1993. 44: p. 121-31.
    2. Sattar, N., et al., Metabolic syndrome with and without C-reactive protein as a
    predictor of coronary heart disease and diabetes in the West of Scotland
    Coronary Prevention Study. Circulation, 2003. 108(4): p. 414-9.
    3. Huang, P.L., A comprehensive definition for metabolic syndrome. Dis Model
    Mech, 2009. 2(5-6): p. 231-7.
    4. Opie, L.H., Metabolic syndrome. Circulation, 2007. 115(3): p. e32-5.
    5. Lakka, H.M., et al., The metabolic syndrome and total and cardiovascular
    disease mortality in middle-aged men. JAMA, 2002. 288(21): p. 2709-16.
    6. Ford, E.S., W.H. Giles, and W.H. Dietz, Prevalence of the metabolic
    syndrome among US adults: findings from the third National Health and
    Nutrition Examination Survey. JAMA, 2002. 287(3): p. 356-9.
    7. Park, Y.W., et al., The metabolic syndrome: prevalence and associated risk
    factor findings in the US population from the Third National Health and
    Nutrition Examination Survey, 1988-1994. Arch Intern Med, 2003. 163(4): p.
    427-36.
    8. Ford, E.S. and W.H. Giles, A comparison of the prevalence of the metabolic
    syndrome using two proposed definitions. Diabetes Care, 2003. 26(3): p.
    575-81.
    9. Assmann, G., et al., Harmonizing the definition of the metabolic syndrome:
    comparison of the criteria of the Adult Treatment Panel III and the
    International Diabetes Federation in United States American and European
    populations. Am J Cardiol, 2007. 99(4): p. 541-8.
    10. Alberti, K.G. and P.Z. Zimmet, Definition, diagnosis and classification of
    diabetes mellitus and its complications. Part 1: diagnosis and classification of
    diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998.
    15(7): p. 539-53.
    11. Third Report of the National Cholesterol Education Program (NCEP) Expert
    Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in
    Adults (Adult Treatment Panel III) final report. Circulation, 2002. 106(25): p.
    3143-421.
    12. Zimmet, P., et al., The metabolic syndrome: a global public health problem
    and a new definition. J Atheroscler Thromb, 2005. 12(6): p. 295-300.
    13. Grundy, S.M., et al., Diagnosis and management of the metabolic syndrome:
    40
    an American Heart Association/National Heart, Lung, and Blood Institute
    scientific statement: Executive Summary. Crit Pathw Cardiol, 2005. 4(4): p.
    198-203.
    14. Alberti, K.G., et al., Harmonizing the metabolic syndrome: a joint interim
    statement of the International Diabetes Federation Task Force on
    Epidemiology and Prevention; National Heart, Lung, and Blood Institute;
    American Heart Association; World Heart Federation; International
    Atherosclerosis Society; and International Association for the Study of Obesity.
    Circulation, 2009. 120(16): p. 1640-5.
    15. Balkau, B., et al., Frequency of the WHO metabolic syndrome in European
    cohorts, and an alternative definition of an insulin resistance syndrome.
    Diabetes Metab, 2002. 28(5): p. 364-76.
    16. Anand, S.S., et al., Relationship of metabolic syndrome and fibrinolytic
    dysfunction to cardiovascular disease. Circulation, 2003. 108(4): p. 420-5.
    17. Gupta, R., et al., Prevalence of metabolic syndrome in an Indian urban
    population. Int J Cardiol, 2004. 97(2): p. 257-61.
    18. Kozan, O., et al., Prevalence of the metabolic syndrome among Turkish adults.
    Eur J Clin Nutr, 2007. 61(4): p. 548-53.
    19. Zabetian, A., F. Hadaegh, and F. Azizi, Prevalence of metabolic syndrome in
    Iranian adult population, concordance between the IDF with the ATPIII and
    the WHO definitions. Diabetes Res Clin Pract, 2007. 77(2): p. 251-7.
    20. Park, H.S., et al., The metabolic syndrome and associated lifestyle factors
    among South Korean adults. Int J Epidemiol, 2004. 33(2): p. 328-36.
    21. Tan, C.E., et al., Can we apply the National Cholesterol Education Program
    Adult Treatment Panel definition of the metabolic syndrome to Asians?
    Diabetes Care, 2004. 27(5): p. 1182-6.
    22. Gu, D., et al., Prevalence of the metabolic syndrome and overweight among
    adults in China. Lancet, 2005. 365(9468): p. 1398-405.
    23. Feng, Y., et al., Prevalence of metabolic syndrome and its relation to body
    composition in a Chinese rural population. Obesity (Silver Spring), 2006.
    14(11): p. 2089-98.
    24. Morales, D.D., et al., Metabolic syndrome in the Philippine general
    population: prevalence and risk for atherosclerotic cardiovascular disease
    and diabetes mellitus. Diab Vasc Dis Res, 2008. 5(1): p. 36-43.
    25. Wang, W., et al., Epidemiological investigation of metabolic syndrome and
    analysis of relevant factors in north-eastern China. J Int Med Res, 2010. 38(1):
    p. 150-9.
    26. Ko, G.T., et al., High prevalence of metabolic syndrome in Hong Kong
    41
    Chinese--comparison of three diagnostic criteria. Diabetes Res Clin Pract,
    2005. 69(2): p. 160-8.
    27. Pan, W.H., W.T. Yeh, and L.C. Weng, Epidemiology of metabolic syndrome
    in Asia. Asia Pac J Clin Nutr, 2008. 17 Suppl 1: p. 37-42.
    28. Chuang, S.Y., C.H. Chen, and P. Chou, Prevalence of metabolic syndrome in
    a large health check-up population in Taiwan. J Chin Med Assoc, 2004.
    67(12): p. 611-20.
    29. Chen, H.J. and W.H. Pan, Probable blind spot in the International Diabetes
    Federation definition of metabolic syndrome. Obesity (Silver Spring), 2007.
    15(5): p. 1096-100.
    30. Chen, H.J., et al., Influence of metabolic syndrome and general obesity on the
    risk of ischemic stroke. Stroke, 2006. 37(4): p. 1060-4.
    31. Zabetian, A., et al., Weight change and incident metabolic syndrome in
    Iranian men and women; a 3 year follow-up study. BMC Public Health, 2009.
    9: p. 138.
    32. Kim, B.J., et al., Association of smoking status, weight change, and incident
    metabolic syndrome in men: a 3-year follow-up study. Diabetes Care, 2009.
    32(7): p. 1314-6.
    33. Sheu, W.H., et al., Predictors of incident diabetes, metabolic syndrome in
    middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan. Diabetes
    Res Clin Pract, 2006. 74(2): p. 162-8.
    34. Yang, F.Y., M.L. Wahlqvist, and M.S. Lee, Body mass index (BMI) as a
    major factor in the incidence of the metabolic syndrome and its constituents in
    unaffected Taiwanese from 1998 to 2002. Asia Pac J Clin Nutr, 2008. 17(2): p.
    339-51.
    35. Chobanian, A.V., et al., The Seventh Report of the Joint National Committee
    on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:
    the JNC 7 report. JAMA, 2003. 289(19): p. 2560-72.
    36. Heng, D., et al., Modification of the NCEP ATP III definitions of the metabolic
    syndrome for use in Asians identifies individuals at risk of ischemic heart
    disease. Atherosclerosis, 2006. 186(2): p. 367-73.
    37. Sjostrom, L., et al., Lifestyle, diabetes, and cardiovascular risk factors 10
    years after bariatric surgery. N Engl J Med, 2004. 351(26): p. 2683-93.
    38. Esposito, K., et al., Effect of weight loss and lifestyle changes on vascular
    inflammatory markers in obese women: a randomized trial. JAMA, 2003.
    289(14): p. 1799-804.
    39. Moore, L.L., et al., Can sustained weight loss in overweight individuals
    reduce the risk of diabetes mellitus? Epidemiology, 2000. 11(3): p. 269-73.
    42
    40. Tuomilehto, J., et al., Prevention of type 2 diabetes mellitus by changes in
    lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 2001.
    344(18): p. 1343-50.
    Advisor
  • Jorng-tzong Horng(xv)
  • Files
  • 985302023.pdf
  • approve in 1 year
    Date of Submission 2011-08-28

    [Back to Results | New Search]


    Browse | Search All Available ETDs

    If you have dissertation-related questions, please contact with the NCU library extension service section.
    Our service phone is (03)422-7151 Ext. 57407,E-mail is also welcomed.